LEGN

MKT CAP:$5B

Legend Biotech Corp

Market Cap

$5B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$31.52+$10.01 (+46.54%)

Jun 8, 2026

52W High $44.3252W Low $16.65

Company Details

Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, an...

CEO

—

IPO Date

Jun 5, 2020

Website

legendbiotech.com

Key Metrics TTM

Revenue

$1.1B

+56.4% YoY

Net Income

-$250M

EPS (Diluted)

Free Cash Flow

-$236M

Revenue / Share

$6.16

Gross Margin

55.0%

Operating Margin

-11.9%

Net Margin

-22.0%

FCF Margin

-20.8%

P/S

4.2x

P/E

Earnings Reports

Q2 2026

Aug 10, 2026

PENDING

Q1 2026

May 12, 2026

$305M+56.4%

FY 2025

Mar 10, 2026

$1.0B+64.0%

Q4 2025

Mar 10, 2026

$306M+64.3%

Q3 2025

Nov 12, 2025

$272M+70.0%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee